News | March 24, 2008

New Coronary Stent Gets CE Mark as Bare Metal Stent

March 25, 2008 - Medlogics Device Corp.s’ COBRA Coronary Stent System, a new thin, bare metal stent (BMS), received the CE Mark based on the chronic preclinical implants performed at Saint Joseph’s Translational Research Institute (SJTRI), which demonstrated the safety and efficacy of the stent.

The COBRA Coronary Stent System combines cobalt super alloy for thinner struts without sacrificing radial strength. According to the manufacturer, published studies have demonstrated a direct correlation between strut thickness and restenosis rates, and the COBRA stent is approximately 15 percent thinner than other BMS coronary stents.

In addition to working their BMS program, SJTRI is conducting further research with Medlogics on their drug-eluting stent programs. Medlogics’s drug-coated stent has a silica-based coating that is gradually absorbed by the body after delivery of the drug, potentially reducing the risk of clotting and the burden of pharmacotherapy.

For more information: and

Related Content

FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Onyx DES 2.0 mm stent meets primary endpoints in small vessels
News | June 12, 2017
June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failur
First Pennsylvania Patient Treated in LEADERS FREE II Trial of BioFreedom Drug-Coated Stent
News | Stents Drug Eluting| May 12, 2017
PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial assessing the safety and...
Resolute Onyx DES, drug eluting stent, medtronic, gains FDA approval
Technology | Stents Drug Eluting| May 01, 2017
May 1, 2017 — The U.S.
Sponsored Content | Videos | Stents Drug Eluting| May 01, 2017
This video, provided by Medtronic, demonstrates the Resolute Onyx coronary stent.
Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center
News | Stents Bifurcation| March 31, 2017
Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side Branch Stent was...
Sponsored Content | Videos | Stents Bioresorbable| March 30, 2017
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses t
Gore Tigris Vascular Stent, Health Canada approval, PAD, peripheral artery disease
News | Stents Peripheral| March 16, 2017
W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris Vascular Stent, a...
Sponsored Content | Videos | Stents Bifurcation| March 06, 2017
This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent.
Overlay Init